Skip to main content
Clinical Trials/ACTRN12618000110280
ACTRN12618000110280
Terminated
未知

Evaluation of pharmacokinetic and clinical outcomes with standard empiric beta-lactam antibiotic dosing strategies in patients with febrile neutropenia being treated with intensive chemotherapy for haematological malignancies, including assessment of alterations in renal clearance in the setting of sepsis.

Cancer Care Services, RBWH0 sites100 target enrollmentJanuary 24, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Febrile neutropenia
Sponsor
Cancer Care Services, RBWH
Enrollment
100
Status
Terminated
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 24, 2018
End Date
TBD
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Cancer Care Services, RBWH

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials